A two-cohort, open-label, single arm, multicenter study to evaluate efficacy, safety and tolerability,pharmacokinetics and pharmacodynamics, of emapalumab in children and
adults with

Project: Research project

Project Details

Description

A two-cohort, open-label, single arm, multicenter study to evaluate efficacy, safety and tolerability, pharmacokinetics and pharmacodynamics, of emapalumab in children and
adults with
StatusActive
Effective start/end date7/26/218/31/26

Funding

  • SOBI, INC

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.